Fundraising Fox

OverT Bio

New York, US · Founded 2022 · 4 known investors

overt.bio ↗

Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms. The company builds programmable immunotherapies targeting cancer patients.

AI & Machine LearningBiotechMedical Devices

Founders & leadership

DL
Dr. LegutCo-Founder and CEO
DS
Dr. SanjanaCo-Founder
ML
Mateusz LegutExecutive Officer, Director
VB
Vasudev BaileyDirector
SC
Sara ChoiDirector
NS
Neville SanjanaDirector

Investors · 4

Artis VenturesSan Francisco · $50K – $25Mvia Vasudev Bailey · board
Civilization Ventures Management, LlcTiburon · $1M – $10M
FusionPalo Alto · $500K – $1M
WingPalo Alto · $200K – $20M

Reported raises · per SEC filings

Form D private placements
▶$16MraisedMay 2024 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mateusz LegutExecutive Officer, Director
  • Vasudev BaileyDirector
  • Sara ChoiDirector
  • Neville SanjanaDirector
Offering amount
$17M
Amount sold
$16M
First sale
Apr 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news